Prognostic Significance of the Deleted in Colorectal Cancer Gene Protein Expression in High-Risk Resected Gastric Carcinoma

References

• Alexander H.R., Kelsen D.P., Tepper J.E. Cancer of the stomach. Cancer. Principles and Practice of Oncology, V.T. DeVita, S. Hellman, S.A. Rosenberg. 5th Ed., Lippincot-Raven Publishers, Philadelphia 1997; 1021–1053
   Google Scholar
• McKean-Cowdin R., Feigelson H.S., Ross R.K., Pike M.C., Henderson B.E. Declining cancer rates in the 1990s. J. Clin. Oncol. 2000; 18: 2258–2268
   PubMed Web of Science ®Google Scholar
• Bamias A., Pavlidis N. Systemic chemotherapy in gastric cancer. Where do we stand today?. Oncologist 1998; 3: 171–177
   PubMedGoogle Scholar
• Fuchs C.S., Mayer R.J. Gastric carcinoma. N. Engl. J. Med. 1995; 333(1)32–41
   PubMed Web of Science ®Google Scholar
• Kelsen D.P. Adjuvant and neoadjuvant therapy for gastric cancer. Semin. Oncol. 1996; 23(3)379–389
   PubMed Web of Science ®Google Scholar
• Gossios K., Tsianos E.V., Nicolson V., Bamias A., Cunningham D., Husband J. CT evaluation of the resectability of gastric cancer postchemotherapy. Abdom. Imaging 1996; 21: 293–298
   PubMed Web of Science ®Google Scholar
• Joypaul B.V., Hopwood D., Newman E.L., Qureshi S., Grant A., Ogston S.A., Lane D.P., Cuschieri A. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br. J. Cancer 1994; 69: 943–946
   PubMed Web of Science ®Google Scholar
• Allgayer H., Babic R., Gruetzner K.U., Tarabichi A., Schildberg F.W., Heiss M.M. C-erb-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J. Clin. Oncol. 1999; 18: 2201–2209
   Web of Science ®Google Scholar
• Cho K.R., Fearon E.R. DCC: Linking tumor suppressor genes and altered cell surface interactions in cancer?. Eur. J. Cancer 1995; 31A(7/8)1055–1060
   PubMed Web of Science ®Google Scholar
• Uchino S., Tsuda H., Noguchi M., Yokota J., Terada M., Saito T., Kobayashi M., Sugimura T., Hirobashi S. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992; 52: 3099–3102
   PubMed Web of Science ®Google Scholar
• Fang D.C., Jass J.R., Wang D.X. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J. Clin. Pathol. 1998; 51: 593–596
   PubMed Web of Science ®Google Scholar
• Cropp C.S., Lidereau R., Campbell G., Champene M.H., Callahan R. Loss of heterozygosity on chromosome 17 and 18 in breast carcinoma: two additional regions identified. Proc. Natl Acad. Sci. USA 1990; 87: 7737–7741
   PubMed Web of Science ®Google Scholar
• Gao X., Honn K.V., Grignon D., Sakr W., Chen Y.Q. Frequent loss of expression and loss of heterozygosity of putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 1993; 53: 2723–2727
   PubMed Web of Science ®Google Scholar
• Peng H.Q., Bailey D., Bronson D., Goss P.D., Hong D. Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res. 1995; 55: 2871–2875
   PubMed Web of Science ®Google Scholar
• Shibata D., Reale M.A., Lavin P., Silverman M., Fearon E.R., Steele G., Jessup J.M., Loda M., Summerhayes I.C. The DCC protein and prognosis in colorectal cancer. N. Engl. J. Med. 1996; 335: 1727–1732
   PubMed Web of Science ®Google Scholar
• Sun X.F., Rutten S., Zhang H., Nordenskjold B. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma. J. Clin. Oncol. 1999; 17: 1745–1750
   PubMed Web of Science ®Google Scholar
• Armitage P., Berry G. Statistical Methods in Medical Research. Blackwell Scientific Publications, OxfordUnited Kingdom 1994
   Google Scholar
• Kaplan E., Meirer P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457–481
   Web of Science ®Google Scholar
• Cox D.R. Regression models and life tables. J. R. Stat. Soc. B 1972; 34: 187–220
   Google Scholar
• Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., Bos J.L. Genetic alterations during colorectal cancer development. N. Engl. J. Med. 1988; 319: 453–456
   Google Scholar
• Cho K.R., Oliner J.D., Simons J.W., Hedrick L., Fearon E.R., Preisinger A.C., Hedge P., Silverman G.A., Vogelstein B. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 1994; 19: 525–531
   PubMed Web of Science ®Google Scholar
• Hohne M.W., Halatsch M.E., Kahl G.F., Weinel R.G. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 1992; 52: 2616–2619
   PubMed Web of Science ®Google Scholar
• Murty V.V., Li R.G., Houldsworth J., Bronson D.L., Reuter V.E., Bosl G.J., Chaganti R.S. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors. Oncogene 1994; 9: 3227–3331
   PubMed Web of Science ®Google Scholar
• Hedrick L., Cho K.R., Fearon E.R., Wu T.C., Kinzler K.W., Vogelstein B. The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev. 1994; 8: 1174–1183
   PubMed Web of Science ®Google Scholar
• Turley H., Pezella F., Kocialkowski S., Conley M., Kaklamanis L., Fawcett J., Simmons D., Harris A.L., Gather K.C. The distribution of the deleted in colon cancer (DCC) protein in human tissues. Cancer Res. 1995; 55: 5628–5631
   PubMed Web of Science ®Google Scholar
• Gotley D.C., Reeder J.A., Fawcett J., Walsh M.D., Bates P., Simmons D.L., Antalis T.M. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene 1996; 13: 787–795
   PubMed Web of Science ®Google Scholar
• Fang D.C., Jass J., Wang D.X., Zhou X.D., Luo Y.H., Young J. Infrequent loss of heterozygosity of APC/MCC and DCC genes in gastric cancers showing DNA microsatellite instability. J. Clin. Pathol. 1999; 52: 504–508
   PubMed Web of Science ®Google Scholar
• Battifora H. P53 immunohistochemistry: a word of caution. Hum. Pathol. 1994; 25(5)435–437
   PubMed Web of Science ®Google Scholar
• Baas I.O., Mulder J.W., Offerhaus G.J., Vogelstein B., Hamilton S.R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol. 1994; 172: 5–12
   PubMed Web of Science ®Google Scholar
• Yonemura Y., Kimura H., Fushida S., Tugawa K., Nakai Y., Kaji M., Fonseca L., Yamaguchi A., Miyazaki I. Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 1993; 71: 2448–2453
   PubMed Web of Science ®Google Scholar
• Kakeji Y., Maehara Y., Adachi Y., Baba H., Mori M., Furusawa M., Sugimachi K. Proliferative activity as a prognostic factor in Bormann type 4 gastric carcinoma. Br. J. Cancer 1994; 69: 749–753
   PubMed Web of Science ®Google Scholar
• Maeda K., Chung Y.S., Takatsuka S., Ogawa Y., Onoda N., Sawada T., Kato Y., Nitta A., Arimoto Y., Kondo Y., Sowa M. Tumor angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br. J. Cancer 1995; 72: 319–323
   PubMed Web of Science ®Google Scholar
• Jen J., Kim H., Piantadosi S., Liu Z.F., Levitt R.C., Sistonen P., Kinzler K.W., Vogelstein B., Hamilton S.R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. 1994; 331: 213–221
   PubMed Web of Science ®Google Scholar
• Howe J.R., Roth S., Ringold J.C., Summers R.W., Jarvinen H.J., Sistonen P., Tomlinson I.P., Houlston R.S., Bevan S., Mitus F.A., Stone E.M., Aaltonen L.A. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998; 280: 1086–1088
   PubMed Web of Science ®Google Scholar
• Blobe G.C., Schiemann W.P., Lodish H.F. The role of transforming growth factor a in human disease. N. Engl. J. Med. 2000; 342: 1350–1359
   PubMed Web of Science ®Google Scholar